John Raemaekers

Second Cancer Risk Up to 40 Years after Treatment for Hodgkin’s Lymphoma

Michael Schaapveld, Berthe M.P. Aleman, Anna M. van Eggermond et al. · New England Journal of Medicine · 2015 · 626 citations · Full text

Medicine, Oncology, Cancer Control +13

Early Positron Emission Tomography Response–Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial

Marc André, T. Girinsky, Massimo Federico et al. · Journal of Clinical Oncology · 2017 · 532 citations · Full text

Medicine, Oncology, Pharmacology +17

Cardiovascular Disease After Hodgkin Lymphoma Treatment

Frederika A. van Nimwegen, Michael Schaapveld, Cécile P.M. Janus et al. · JAMA Internal Medicine · 2015 · 502 citations · Full text

Medicine, Cardiology, Oncology +15

Chemotherapy plus Involved-Field Radiation in Early-Stage Hodgkin's Disease

Christophe Fermé, Houchingue Eghbali, J.H. Meerwaldt et al. · New England Journal of Medicine · 2007 · 446 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Omitting Radiotherapy in Early Positron Emission Tomography–Negative Stage I/II Hodgkin Lymphoma Is Associated With an Increased Risk of Early Relapse: Clinical Results of the Preplanned Interim Analysis of the Randomized EORTC/LYSA/FIL H10 Trial

John Raemaekers, Marc André, Massimo Federico et al. · Journal of Clinical Oncology · 2014 · 383 citations · Full text

Medicine, Nuclear Medicine, Oncology +17